Loading...
TRIM37 antibody

22055

TRIM37 antibody

TRIM37 antibody (catalogue number 22055) is a rabbit-derived primary antibody validated for WB IHC IF, reactive with Human samples. It targets E3 ubiquitin-protein ligase TRIM37 (TRIM37): E3 ubiquitin-protein ligase required to prevent centriole reduplication. Supplied as 100ul at ₪1,953.80; the final price is confirmed on your quote and the lot certificate of analysis ships with the order.

Primary AntibodyHostRabbit
Host / source
Rabbit
Reactivity
Human
Applications
WB IHC IF
UniProt ID
O94972
Gene
TRIM37
Target organism
Homo sapiens
Catalogue number
22055
Brand
LABO Scientific
Storage
Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.

Target background

Target: E3 ubiquitin-protein ligase TRIM37 (TRIM37) · Homo sapiens

E3 ubiquitin-protein ligase required to prevent centriole reduplication. Probably acts by ubiquitinating positive regulators of centriole reduplication. Mediates monoubiquitination of 'Lys-119' of histone H2A (H2AK119Ub), a specific tag for epigenetic transcriptional repression: associates with some Polycomb group (PcG) multiprotein PRC2-like complex and mediates repression of target genes.

Subcellular location: Chromosome; Cytoplasm, perinuclear region; Peroxisome membrane

Tissue specificity: Ubiquitous. Highly expressed in testis, while it is weakly expressed in other tissues

Sequence length: 964 aa · 107906 Da

Protein background from UniProtKB, licensed under CC BY 4.0. Describes the target antigen, not this product.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Storage
Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.